Results 101 to 110 of about 51,447 (251)

Analysis of a possible association between oral lichen planus and drug intake. A controlled study [PDF]

open access: yes, 2011
Objectives: To investigate whether daily systemic and/or topical medication contributes to the development of oral lichen planus (OLP) lesions. Study Design: The study involved 110 OLP patients and 76 control subjects, matched by age, race and sex.
dos Santos, Carlos H. R.   +4 more
core   +1 more source

Oral lichenoid lesions related to contact with dental materials: A literature review [PDF]

open access: yes, 2009
Oral lichenoid lesions related to contact are defined as oral-cavity eruptions with an identifiable etiology, and are clinically and histologically similar to oral lichen planus.
Bullon, Pedro   +4 more
core  

Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus [PDF]

open access: yes, 2015
Background: Oral lichen planus (OLP) is a T cell mediated immune response. T cells locally present in the involved tissues release cytokines like interleukin-6 (IL-6), which contributes to pathogenesis of OLP.
Garg, Vijay K.   +4 more
core   +1 more source

Inflammatory niches as spatial drivers of disease mechanisms and targets for personalized treatment

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study provides a comprehensive review of how spatial transcriptomics reveals disease‐specific inflammatory niches across multiple skin disorders, highlighting key immune–stromal, neuro–immune and metabolic interactions that were previously unappreciated in non‐spatial analyses. Abstract Disease states are increasingly recognized as being shaped by
Rundong Jiang   +3 more
wiley   +1 more source

A retrospective clinicopathological study on oral lichen planus and malignant transformation: analysis of 518 cases [PDF]

open access: yes, 2012
Objective: To investigate the epidemiological and clinical characteristics of a relatively large cohort of patients with oral lichen planus (OLP) from eastern China.
Feng, Jin Qiu   +5 more
core   +1 more source

Two Cases of Less Common Clinical Presentations of Allergic Contact Dermatitis to Acrylates in UV‐Cured Nail Polish

open access: yes
Contact Dermatitis, EarlyView.
Léopoldine Vernhet   +4 more
wiley   +1 more source

Global consensus on the management of melanin hyperpigmentation disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron   +9 more
wiley   +1 more source

The role of gastrointestinal pathology in the development and severity of oral lichen planus

open access: yesБюллетень сибирской медицины, 2018
The aim is to determine the most significant predictors of the oral lichen planus in patients with gastrointestinal pathology.Materials and methods. The study was performed of 40 patients aged 41 to 86 years with oral lichen planus.
M. A. Titarenko   +3 more
doaj   +1 more source

Survey of Relationship between Hepatitis C and Lichen planus (among dermatology outpatients of Imam Hospital of Ardabil city) . [PDF]

open access: yes
Background and aim :Lichen planus is classified as a common and chronic papulo – squamous disease. It has been associated with liver disease particularly hepatitis C virus (HCV) infection, in several studies. This study aims to evaluate the controversial
انعام زاده, فرناز   +1 more
core  

Dermatology 2.0: Precision medicine for inflammatory skin diseases

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Digital immune mapping of transcriptomics profiles from inflammatory skin disease biopsies enables precise molecular diagnosis, quantification of immune modules and personalized therapy selection by matching dominant immune signatures to targeted treatments.
Jeremy Di Domizio   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy